Sensus Healthcare Inc SRTS.OQ SRTS.O is expected to show a rise in quarterly revenue when it reports results on August 7 for the period ending June 30 2025
The Boca Raton Florida-based company is expected to report a 0.7% increase in revenue to $9.301 million from $9.24 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for Sensus Healthcare Inc is for earnings of 3 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Sensus Healthcare Inc is $11.00, about 52.3% above its last closing price of $5.25
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | 0.03 | 0.03 | -0.16 | Missed | -570.6 |
Dec. 31 2025 | 0.13 | 0.12 | 0.09 | Missed | -27.4 |
Sep. 30 2024 | 0.00 | -0.01 | 0.07 | Beat | 800 |
Jun. 30 2024 | 0.02 | 0.02 | 0.10 | Beat | 328.6 |
Mar. 31 2024 | -0.06 | -0.05 | 0.14 | Beat | 354.5 |
Dec. 31 2023 | 0.14 | 0.12 | 0.26 | Beat | 113.1 |
Sep. 30 2023 | -0.01 | -0.02 | -0.09 | Missed | -400 |
Jun. 30 2023 | -0.08 | -0.08 | -0.02 | Beat | 73.7 |
This summary was machine generated August 5 at 21:52 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)